Alterations in Coxsackievirus 134 Heart Muscle Disease in ICR Swiss Mice
by Anti-thymocyte Serum (Accepted 13 July 1982) SUMMARY Coxsackievirus B4 (CB4) infection in infant ICR Swiss mice induces synchronous peaks in both virus titres and pathologic changes in the heart. Among surviving mice, transmural necrosis is followed by fibrosis and ventricular aneurysm. Rabbit antimouse thymocyte serum (ATS) was given before CB4 infection to determine the effects of thymus-dependent functions upon the course of disease. The mortality in ATStreated mice was 75-9 % (65 of 83 mice died) compared to 21.3 % (16 of 75 mice died) in normal rabbit serum-treated controls. Pathologic studies showed that ATS-treated mice had more extensive myofibre necrosis and subsequent mineralization, but during the first 10 days of infection, leukocytic infiltration was decreased. Splenic follicles were not present until the 17th day after infection in this treated group. Serum CB4-neutralizing antibodies were similar in mice from the group treated with ATS and normal rabbit serum. These findings indicate that ATS-suppressible functions contribute importantly to virus elimination, perhaps by an increase in macrophage phagocytosis of CB4.
Intraperitoneal inoculation of coxsackievirus B3 (CB3) into young CD-1 or Balb/c mice induces myocarditis which is dependent upon a T-cell-dependent cytotoxic mechanism (Wong et al., 1977a; Woodruff & Woodruff, 1974) . Anti-thymocyte serum (ATS) suppressed myocardial tissue injury and inflammation. T-cell deprivation protected Balb/c mice against lethal infection as well. During the first week after ATS, virus-neutralizing antibody to CB3 was normal, but later, antibody was;decreased. In the present study, we gave ATS to outbred ICR Swiss mice with coxsackievirus B4 (CB4) infection. Myofibre necrosis appeared to be directly related to CB4-induced cytopathic effects (Khatib et al., 1980) and in contrast to CB3 murine infection, ATS augmented virulence.
The Dowell strain of CB4, which was isolated from the heart of an infant dying of myocarditis, was used after two passages in Vero monkey kidney tissue cultures. The virus was re-identified by neutralization with hyperimmune sera (Microbiological Associates, Bethesda, Md., U.S.A.). Rabbit anti-mouse thymocyte serum Lot no. 13-9226 (ATS) was obtained from Microbiological Associates. Its haemolytic activity was 1 : 128, while its cytotoxicity titre against thymocytes was 1:3200. Pregnant Swiss-Webster ICR mice were purchased (Charles River Breeding Laboratory, Wilmington, Mass., U.S.A.) and their litters assigned at random to one of three experimental groups, which were treated as follows.
Group I (CB4 plus ATS) received an intraperitoneal (i.p.) injection of 0.1 ml of undiluted ATS on each of the first 3 days after delivery. One h after the third dose of ATS, mice received an i.p. injection of 104 TCIDs0 of CB4. Group II (CB4 plus NRS) was similar to group I except that, in place of ATS, normal rabbit serum was used. For group III (NS), the procedure was as for group I, except that mice received normal saline in place of ATS, and 0-1 ml of virus-free, Vero tissue culture suspension in place of CB4.
Each mouse from the 3 groups was examined daily over 90 days for clinical signs of illness, or death. Before autopsies, and under ether anaesthesia, each mouse was weighed. From each cohort, 5 to 10 mice were killed with an overdose of ether and exsanguinated by cutting axillary veins at 2, 4, 5, 7, 10, 17, 23, 30, 45, 60 and 90 days after the final injection. Blood was collected, and the heart, thymus and spleen were removed and weighed.
At autopsies on days 2, 4, 5, 7 and 10 after infection, blood, heart, thymus and spleen were (2) examined for virus content (Khatib et al., 1980) . Virus titrations were also done on hearts 17 days after infection. Isolates were re-identified as CB4 by neutralization. Type-specific neutralizing antibody titres were determined on individual sera using microtitre plates of Vero monkey kidney tissue cultures and 10 z TCIDs0 CB4 (Khatib et al., 1980) . Endpoints required complete inhibition of cytopathic effects when virus controls showed dissolution of the tissue cultures.
Histopathologic examinations of heart and spleen were conducted blind. Hearts were cut into three portions by two sections. From the top of each specimen ten sections each of 6 Ixm were made. Pathologic changes in the heart were graded on a scale of 1 + to 4 + according to five categories: necrosis; inflammatory cells; mineralization; fibrosis; and thinning of the myocardial wall. Spleens were cut longitudinally into two portions and sections of 5 ~tm were made from each portion. Lymphocyte follicles in the spleen were identified and counted. The thymus was not examined histologically. All sections were stained with haematoxylin and eosin.
Deaths occurring within the first 5 days of life were considered to be the result of the trauma of inoculations and were excluded from calculations of definite CB4-related mortality. From the 83 of the 168 mice surviving beyond this period in group I (CB4 plus ATS), the 75 of 153 in group II (CB4 plus NRS), and the 39 of 72 in group III (NS), 75.9~, 21-3~ and 10.3~ died. Mortality was significantly increased in group I (P < 0-05 by Chi-squared analysis).
Coxsackievirus B4 was isolated from the blood, heart, thymus and spleen of infected mice (Table 1) . On days 2, 4 and 5 after infection, mice in group I (CB4 plus ATS) had higher mean virus titres in the blood than mice in group II (CB4 plus NRS). On the 10th day, the mean CB4 titre in blood (group I) was 101"1 TCIDso ml, but none of the six samples from group II contained any virus (P < 0.05). Likewise, CB4 titres in the heart were higher in ATS-treated mice (days 2, 4, 5, 7 and 10), and CB4 was still present on day 17 (group I), but at this time, cardiac CB4 had been cleared in group II (P < 0.05). In the thymus, although mean CB4 titres were higher in group I than in group II on each day tested (days 2, 4 and 5), the differences were not statistically significant. However, CB4 titres in the spleen were significantly higher on day 5 (P < 0.001) and virus still persisted on day 10 (group I). The spleens from five mice (group II) on day 10 had no CB4 (P < 0-01).
Neutralizing antibodies to CB4 were not present in mice from group III (NS) and first Fig. 1 . Representative spleens from 8-day-old ICR Swiss mice 5 days after infection with coxsackievirus B4 in subjects receiving normal rabbit serum (group II, CB4 plus NRS) or antithymocyte serum (group I, CB4 plus ATS) are shown ( x 25). Lymphocytic follicles (arrow A) are easily seen in the normal spleen (group II), but these areas are absent (arrow B) in the spleens of ATS-treated mice (group I). appeared in groups I (CB4 plus ATS) and II (CB4 plus NRS) on day 23 after infection. Virus elimination from both the blood and spleen from mice in group II was complete on day 10 before type-specific CB4-neutralizing antibodies were found in serum. From days 23 to 90 after infection, neutralizing antibody titres in groups I and II were similar in time of appearance and magnitude. No differences were detected between the organ-to-body weight ratios of groups I (CB4 plus ATS) and II (CB4 plus NRS) from days 2 to 24 after infection. Sections of spleens from mice in group III (NS) showed a normal distribution of red and white pulp. Lymphocytic follicles were seen in most normal spleens (31 of 39 specimens, 79.5~o), but germinal centres were rarely evident. Mice in group II (CB4 plus NRS) showed normal numbers of lymphocytic follicles (45 of 56 specimens, 80.4~o); an occasional germinal centre was found. Mice in group I (CB4 plus ATS) had normal splenic red pulp, but lymphocytic follicles were rarely seen during the first 10 days after infection. Only 3 of 17 spleens, 17-6~ (group I) compared to 10 of 21 spleens, 47.6~ (group II) and 16 of 24 spleens, 66.7~ (group III) showed lymphocytic follicles (P < 0.05, Fig.  1 ). Beyond the 10th day of infection, subjects in group I showed numbers of lymphocytic follicles equal to those of animals in groups II and III.
Groups I (CB4 plus ATS) and II (CB4 plus NRS) had similar numbers of mice with histopathologic changes in the heart: 83.0~ (44 of 53 hearts) with cardiac damage and 92-1 ~ (64 of 78) respectively. Myocardial fibre necrosis with a mixed polymorphonuclear leukocytic infiltrate was again induced in mice from group II (CB4 plus NRS) (Khatib et al., 1982) . Myocardial fibre necrosis occurred in 74.4 ~o of this group, and 71.6 ~o of the mice from group I. The anatomical sites of myofibre necrosis between groups were also similar. Myocardial fibre necrosis in ATS-treated mice, however, was much more extensive. Leukocytic infiltrates within the myocardium occurred in 35.8 % of the specimens examined from group I, but in 59.0~ of similar sections from group II. Inhibition of leukocytic myocardial inflammation in group I Woodruff & Woodruff (1974) .
mice was observed only during the first 10 days after infection (Fig. 2) . Mineralization of necrotic myocardium was found in 39.6~ of hearts from group I but in only 11.5 ~ from group II. Myocardial thinning or aneurysm formation occurred equally in I (24.5 ~ of the mice) and II (30.8~ of the mice). Control mice in group III (NS) showed no gross or microscopic abnormalities. This work with CB4 repeats earlier experiments with CB3 by Woodruff (1974) and Wong et al. (1977b) . In these studies, mice were given antithymocyte serum immediately before infection, and it was found that ATS treatment of CD-1 or Balb/c mice decreased both cardiac tissue injury and inflammatory exudates while lessening mortality of CB3 infected mice (Table 2) . Although synthesis of IgG type-specific CB3-neutralizing antibody was delayed, virus elimination was unaltered. The authors proposed an immunologic specific cytotoxic T-cell mediated mechanism for myocardial injury. We had previously suggested such an immune mechanism, because myocardial pathologic changes followed peak virus titres by 2 to 4 days (Wilson et al., 1969) .
In contrast, ATS treatment of CB4-infected ICR Swiss infant mice increased cardiac tissue injury and mortality, while prolonging virus multiplication. Mineralization in the heart mirrored myofibre necrosis and was also increased. Antibody synthesis (altready naturally delayed in baby mice) was unchanged, but the numbers of lymphocytic follicles and inflammatory cells in the heart were diminished. In the CB4 murine model, peak virus titres and myocardial necrosis occur approximately at the same time after infection (Khatib et al., 1980 (Khatib et al., , 1982 . These data further support the suggestion that CB4-induced myofibre necrosis is a direct cytopathic response to virus replication (Khatib et al., 1980) . Rager-Zisman & Allison (1973a) showed that antibody and host cells collaborated to eliminate coxsackieviruses after infection. The host cells involved were probably macrophages (Loria et al., 1976; Rager-Zisman & Allison, 1973 b) . Depression of the levels of either antibodies or macrophages could increase the severity of infection, as well as its lethality. In the case of ATS-treated CB4-infected mice, antibody did not contribute to the elimination of the viraemia among control mice. Normal baby mice have a delayed synthesis of coxsackievirus neutralizing antibody (Khatib et al., 1980) . Therefore, we conclude that host cells are essential in the absence of antibody to CB4 elimination. It seems entirely possible that T-cells are required for normal phagocytosis by macrophages in baby ICR Swiss mice (Schuit & Powell, 1980) . Further work is still necessary to determine which subset(s) of T-cells participates in this putative helper function for macrophage phagocytosis of CB4. It may be that both the virus type (CB3 or CB4) and mouse strain (CD-1, Balb/c, or ICR Swiss) determine the striking differences of the effects of anti-thymocyte serum upon these CB infections.
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